A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis.
Horne EA, Diaz P, Cimino PJ, Jung E, Xu C, Hamel E, Wagenbach M, Kumasaka D, Wageling NB, Azorín DD, Winkler F, Wordeman LG, Holland EC, Stella N.
Horne EA, et al. Among authors: wageling nb.
Neurooncol Adv. 2020 Dec 3;3(1):vdaa165. doi: 10.1093/noajnl/vdaa165. eCollection 2021 Jan-Dec.
Neurooncol Adv. 2020.
PMID: 33506204
Free PMC article.